title: Treatment of metastatic malignant melanoma with vemurafenib during pregnancy.
authors: Uppsala University, Uppsala University Hospital, Uppsala, Sweden.
authors: Aglaia
authors: A
authors: Maleka
authors: Gunilla
authors: G
authors: Enblad
authors: Gunnar
authors: G
authors: Sjörs
authors: Anna
authors: A
authors: Lindqvist
authors: Gustav J
authors: GJ
authors: Ullenhag
mesh_terms: D000328:Adult; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007231:Infant, Newborn; D008545:Melanoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D009154:Mutation; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D011256:Pregnancy Outcome; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf